Drug intelligence / Profile preview

MicroLactin

Development stage
Unknown
Lead developer
Stolle Milk Biologics
Modality
Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

MicroLactin is a patented milk protein concentrate ingredient developed by Stolle Milk Biologics International (SMBI) as a nutritional supplement for joint health and overall wellness. The active ingredient is a dairy-derived milk protein concentrate obtained from grass-fed New Zealand cows. MicroLactin is marketed as a biologic nutritional supplement ingredient rather than a pharmaceutical drug, administered orally as a dietary supplement or functional food ingredient. The proposed mechanism involves strengthening blood vessel barrier integrity to reduce inflammation by preventing fluid leakage and neutrophil migration to inflamed tissues. It is primarily indicated for supporting joint health, reducing inflammation, and promoting immune and gut health. Clinical trials have shown improvements in joint discomfort, stiffness, and physical function in individuals with joint issues. MicroLactin is self-affirmed as Generally Recognized as Safe (GRAS), is low in lactose, and contains high concentrations of immunoglobulin G (IgG) and other immune factors naturally found in milk.

Brand names
MicroLactin
Other names
milk protein concentrateStolle Milk Protein

Beyond the preview

Go deeper on MicroLactin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroLactin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call